CDK4 and breast carcinoma: Although the mechanisms of resistance to CDK4/6 inhibitors have been described, complex processes remain enigmatic8, 14, 23, 24, 25, 26, 27 therefore understanding the mechanisms of resistance to CDK4/6 inhibitors is important for prolonging the survival and improving the quality of life of patients with breast cancer.28